Yu Renhuan's experience in the treatment of idiopathic membranous nephropathy from the spleen based on intestinal flora

WANG Xiangpeng; ZENG Qin; YANG Jiayi; ZHAN Tian; WANG Dianwen; LI Yihan; YU Renhuan

doi:10.16025/j.1674-1307.2024.04.010

您当前的位置：

首页 >

文章列表页 >

Yu Renhuan's experience in the treatment of idiopathic membranous nephropathy from the spleen based on intestinal flora

更新时间：2024-06-03

- Yu Renhuan's experience in the treatment of idiopathic membranous nephropathy from the spleen based on intestinal flora
- Beijing Journal of Traditional Chinese Medicine Vol. 43, Issue 4, Pages: 381-384(2024)
- 作者机构：
  
  1.北京中医药大学研究生院，北京 100029
  2.中国中医科学研究院西苑医院肾病科，北京 100091
- 作者简介：
- 基金信息：
- DOI：10.16025/j.1674-1307.2024.04.010
  CLC：
- Published：25 April 2024，
  
  Received：30 June 2023，
扫描看全文
王湘鹏，曾勤，杨嘉仪，等.余仁欢基于肠道菌群学说从脾论治特发性膜性肾病经验［J］.北京中医药，2024，43（4）：381-384.

WANG Xiangpeng,ZENG Qin,YANG Jiayi,et al.Yu Renhuan's experience in the treatment of idiopathic membranous nephropathy from the spleen based on intestinal flora[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(04):381-384.
王湘鹏，曾勤，杨嘉仪，等.余仁欢基于肠道菌群学说从脾论治特发性膜性肾病经验［J］.北京中医药，2024，43（4）：381-384. DOI： 10.16025/j.1674-1307.2024.04.010.

WANG Xiangpeng,ZENG Qin,YANG Jiayi,et al.Yu Renhuan's experience in the treatment of idiopathic membranous nephropathy from the spleen based on intestinal flora[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(04):381-384. DOI： 10.16025/j.1674-1307.2024.04.010.

摘要

越来越多的证据表明肠道菌群紊乱可能参与特发性膜性肾病的发生发展。中医学中“脾”的功能可能是通过肠道菌群及其代谢产物所体现。余仁欢教授拟定具有健脾益气、祛湿和络功效的健脾祛湿和络方，通过调节肠道菌群来改善特发性膜性肾病的预后，为临床防治特发性膜性肾病提供新思路和新治法。

Abstract

关键词

特发性膜性肾病脾肾互赞肠道菌群健脾祛湿活络余仁欢

Keywords

references

RUAN XL, JIANG YY, GUO X, et al. Progress in the molecular mechanism of membrane nephropathy[J]. JCMP, 2022,4(3):153-155.

BRENNER BM. The kidney [M].9th ed.Philadelphia: Saunders, 2012:1100-1380.

WOO KT,CHAN CM,LIM C,et al. A global evolutionary trend of the frequency of primary glomerulonephritis over the past four decades[J]. Kidney Dis, 2019,5(4):247-258.

ZHAO YY. Recent advances of gut microbiota in chronic kidney disease patients[J]. Explor Med, 2022,3(3):260-274.

温永天, 王凤云, 唐旭东,等. 从肠道菌群探讨“内伤脾胃,百病由生”的科学内涵[J]. 中华中医药杂志,2022,37(8):4334-4337.

吴成态, 张铭, 张静,等. 健脾益肾法治疗特发性膜性肾病的Meta分析[J]. 中华中医药学刊,2020,38(7):163-168.

MEIJERS BK, EVENEPOEL P. The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression[J]. Nephrol Dial Transplant, 2011,26(3):759-761.

LI M, WEI L, SUN J, et al. Association of gut microbiota with idiopathic membranous nephropathy[J]. BMC Nephrol, 2022,23(1):164.

LANG R, WANG XH, LI AF, et al. Effects of Jian Pi Qu Shi Formula on intestinal bacterial flora in patients with idiopathic membranous nephropathy: A prospective randomized controlled trial[J]. Chronic Dis Transl Med, 2020,6(2):124-133.

SHANG J, ZHANG Y, GUO R, et al. Gut microbiome analysis can be used as a noninvasive diagnostic tool and plays an essential role in the onset of membranous nephropathy[J]. Adv Sci (Weinh), 2022,9(28):e2201581.

WIECH T, REINHARD L, WULF S, et al. Bacterial infection possibly causing autoimmunity: Tropheryma whipplei and membranous nephropathy[J]. Lancet, 2022,400(10366):1882-1883.

MOTAVALLI R, ETEMADI J, SOLTANI-ZANGBAR MS, et al. Altered Th17/Treg ratio as a possible mechanism in pathogenesis of idiopathic membranous nephropathy[J]. Cytokine, 2021,141:155452.

ZHANG Y, ZHAO J, QIN Y, et al. Specific alterations of gut microbiota in patients with membranous nephropathy: A systematic review and meta-analysis[J]. Front Physiol, 2022,13:909491.

ARPAIA N, CAMPBELL C, FAN X, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation[J]. Nature, 2013,504(7480):451-455.

GENG XQ, MA A, HE JZ, et al. Ganoderic acid hinders renal fibrosis via suppressing the TGF-β/Smad and MAPK signaling pathways[J]. Acta Pharmacol Sin, 2020,41(5):670-677.

DONG L, WEI W, HAN M, et al. Utility of non-HDL-C in predicting proteinuria remission of idiopathic membranous nephropathy: a retrospective cohort study[J]. Lipids Health Dis, 2021,20(1):122.

DONG L, LI YQ, GUO SM, et al. Hypercholesterolemia correlates with glomerular phospholipase A2 receptor deposit and serum anti-phospholipase A2 receptor antibody and predicts proteinuria outcome in idiopathic membranous nephropathy[J]. Front Immunol, 2022,13:905930.

COMPANYS J, GOSALBES MJ, PLA-PAGÀ L, et al. Gut microbiota profile and its association with clinical variables and dietary intake in overweight/obese and lean subjects: A cross-sectional study[J]. Nutrients, 2021,13(6):2032.

刘玉旋,李平,梁昌昌,等.276例特发性膜性肾病中医证候分布及其影响因素分析[J].世界中医药,2022,17(22):3229-3234,3241.

郎睿.健脾祛湿和络方治疗特发性膜性肾病的队列研究及基于肠道菌群的机制探索[D].北京:中国中医科学院,2019.

郎睿, 王新慧, 张涛,等. 健脾祛湿和络方治疗特发性膜性肾病的队列研究[J]. 空军医学杂志,2021,37(6):510-514.

张荣融.健脾祛湿和络方治疗特发性膜性肾病的临床观察[D].北京:中国中医科学院,2019.

曾勤.基于CD4+T淋巴细胞探究健脾祛湿和络方治疗特发性膜性肾病的作用机制[D].北京:北京中医药大学,2021.

TAN RZ, DIAO H, LI JC, et al. Astragalus mongholicus bunge and panax notoginseng formula (A&P) combined with bifidobacterium contribute a renoprotective effect in chronic kidney disease through inhibiting macrophage inflammatory response in kidney and intestine[J]. Front Physiol, 2020,11:583668.

STAPPENBECK TS, HOOPER LV, GORDON JI. Developmental regulation of intestinal angiogenesis by indigenous microbes via paneth cells[J]. Proc Natl Acad Sci USA, 2002,99(24):15451-15455.

SEARS CL. A dynamic partnership: celebrating our gut flora[J]. Anaerobe, 2005,11(5):247-251.

LATHROP SK, BLOOM SM, RAO SM, et al. Peripheral education of the immune system by colonic commensal microbiota[J]. Nature, 2011,478(7368):250-254.

LIU R, PENG C, JING D, et al. Lachnospira is a signature of antihistamine efficacy in chronic spontaneous urticaria[J]. Exp Dermatol, 2022,31(2):242-247.

LWANG XH, YANG YN, LIANG Y, et al. Structural modulation of gut microbiota during alleviation of experimental passive Heymann nephritis in rats by a traditional Chinese herbal formula[J]. Biomed Pharmacother, 2022,145:112475.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Discussion on mechanism of treating spleen and stomach with animal faecal drugs

Discussion on connotation of Yiqi Wenyang Huashi method in treating obesity

Treatment of idiopathic membranous nephropathy from Siyin theory in the Synopsis of Golden Chamber

Exploring the treatment of allergic rhinitis with WANG Le-ting's experienced ten acupoints as the main regulating gastrointestinal therapy

Exploration of biological connotation of pathogenesis of non-alcoholic fatty liver disease due to liver depression and spleen deficiency based on liver-bile acid-intestinal microbiota Axis

Related Author

WEI Wei

SU Xiaolan

YANG Yang

WANG Lin

QING Xiangli

ZHANG Kaixuan

ZHAO Yi

WU Rui

Related Institution

中国中医科学院望京医院脾胃病科

北京中医药大学

中国中医科学院广安门医院南区内分泌科

首都医科大学附属北京中医医院北京市中医药研究所

北京中医医院;顺义医院肾病科

⁰